The shares of HCA Healthcare, Inc. (NYSE:HCA) and Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) were among the active stocks of the last trading sessions. HCA Healthcare, Inc. (NYSE:HCA) declined to -0.07% closing at the price of $136.37 whereas the shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) declined -3.48% with the decrease of -0.11 points closing at the price of $3.05. HCA Healthcare, Inc. has currently increase 39.94% in its stock over the period of 6-months while its rival Rigel Pharmaceuticals, Inc. subtracted -20.57% in the previous 6-months.
Now we have to analyze the facts that if the stocks were worthy off investors’ money? The facts to analyze here are risks, profitability, returns and price trends.
Returns and Profitability
Profitability and returns are the main reason of investment, the investors are looking for profits that they get and return they should expect over the period of time.
The first and foremost return that is considered while making an investment is the ROI or Return on Investment. The ROI is the ratio between the profit against the cost of investment. Currently the ROI of HCA Healthcare, Inc. (NYSE:HCA) is 17.8% while the ROI of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) is -79.1%. Another figure that is to be considered while analyzing the profitability of a share is its EBITDA margin, HCA’s EBITDA Margin is 9.64 whereas RIGL’s is -4.14.
Both the profitability ratios suggest that HCA Healthcare, Inc. (NYSE:HCA) is more suitable investment in terms of profitability and return.
EPS & Surprise Factor
HCA Healthcare, Inc. (NYSE:HCA) reported $2.29/share EPS for the previous quarter where analysts were predicting an EPS to be $2.16/share Thus beating the analyst Estimates with a Surprise Factor of 6 Percent. While, Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) reported EPS of $-0.16/share in the last quarter. The analysts projected EPS of $-0.16/share depicting a Surprise of 0 Percent.
Taking a look at Earnings per Share, HCA Healthcare, Inc. tends to be beating the analyst estimates more than Rigel Pharmaceuticals, Inc.. so HCA is more profitable than RIGL.
Technical Analysis of HCA Healthcare, Inc. & Rigel Pharmaceuticals, Inc.
Moving average convergence divergence (MACD) shows that HCA Healthcare, Inc. (NYSE:HCA) is on a PRICE RELATIVITY trend While Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) is on PRICE RELATIVITY trend. The trend for the past 10-days shows that the HCA Healthcare, Inc. was in BEARISH territory and Rigel Pharmaceuticals, Inc. was in BEARISH territory.
HCA’s current statistics gauge that the stock candle is BEARISH with HIGH volatility. While RIGL’s candle is BEARISH with LOW.
EPS Growth Rate: HCA’s 15.08% versus RIGL’s 0%
Another shareholder value can be analyzed through the EPS growth rate; the next 5 years EPS growth rate is predicted by the analysts after the analyzing the previous trends. The next 5 year EPS growth rate of HCA Healthcare, Inc. (NYSE:HCA) is predicted at 15.08% while Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) stands at 0%. These numbers suggest that HCA is more suitable investment in terms of EPS growth rate.
Financial Risk and Liquidity Concerns
The current ratio and the debt ratio are the two ratios that show the investor how quickly the company is able to payout its debt and how quickly it can cover its obligations. The current ratio of HCA stands at 1.4 while RIGL is at 8 whereas the debt ratio of the prior is 0 while the debt ratio of the later is 0.
The values of the both ratios suggest that one is more liquid and other investment is more risk free.
While making an investment, another main factor to consider before investing is the analyst recommendation on the scale of 1 to 5 where 1 is strong buy, 2 is buy, 3 is hold, 4 is Sell and 5 is strong sell. Analyst recommend 2.1 for HCA and 1.7 for RIGL which means HCA has Hold rating whereas RIGL has Buy rating.
Another recommendation of analyst that is to be considered worthy is the price target. The mare price or price trend does not suggest the suitability of a stock. The price target set by analyst is also to be considered while investing as it suggests to what extent the stock will rise or fall in the near future. The price target set for HCA is $141.62 which is 3.71% of its current price while RIGL has price target of 8.14 which is 62.53% of its current price.
Valuation is the process of determining the company’s worth for an investor, the valuation ratios give an insight to that worthiness.
HCA currently has price to earning P/E ratio of 15.55 whereas RIGL has 0 while the forward P/E ratio for the prior stands at 13.61 and for the later it depicts the value of 0.
The price to Book P/B for HCA is 0, Price to Sale is at 1.03 and for RIGL these ratios stand at 4.01 and 188.03.